BaronS.: Overview of progress in interferon research 1979–1983, in: Interferon: Research, clinical application, and regulatory consideration, p. 4. Zoon (Eds.). Elsevier Science. Publ.1983.
2.
BilliauJ. U.: Clinical investigation of interferons: status summary and prospects for the future, p. 499, in: Interferons and Their Applications.CameP. E., CarterW. A. (eds.), Springer-Verlag, Stuttgart1984.
3.
BordenE. C.: Interferons and cancer: How the promise is being kept, in: Interferon5, 1983, p. 43, Academic Press1983.
GuttermanJ. U.: Clinical investigation of interferons: status summary and prospects for the future, p. 499, in: Interferons and Their Applications.CameP. E., CarterW. A. (eds.), Springer-Verlag, Stuttgart1984
7.
IkicD.: Application of human leukocyte interferon in patients with urinary bladder papillomatosis, breast cancer, and melanoma. Lancet, 1; 1022 (1981).
8.
IsaacsA., LindemannJ.: Virus interference. I. The interferon. Proc. Roy. Soc. Med., 147; 258 (1957).
9.
KrimM.: Interferons and their applications: past, presente and future, p. 1, in: Interferons and their applications.CameP. E., CarterW. A. (eds.), Springer-Verlag, Stuttgart1984.
RossiG. B., AffabrisE.: Gli interferoni e il differenziamento cellulare, p. 307, in: La cellula neoplastica.ProdiG., AlberghinaL. (eds.), C.E.A., Milano1986.
12.
StranderH.: The interferon system in antitumor therapy - Some personal views, in: The biology of the interferon system1984, p. 849, KirchnerH., SchnellekensH. (eds.), Elsevier Science Publ.1985.
13.
TaylorJ. L.: The cellular effects of interferon, p. 169. In: Interferons and their application.CameP. E., CarterW. A. (edrs). Springer-Verlag, Stuttgart1984.
14.
Taylor, PapadimitriouJ.: Effects of interferons on cell growth and function, p. 140, in: Interferon, vol. I - General and applied aspects.BilliauA. (ed.). Elsevier Science Publ.1984.
15.
TortiF. M.: Superficial bladder cancers are responsive to alpha 2 interferon administered intravesically (abstract C-628). Proc. Amer. Soc. Clin. Oncol., 3; 160 (1984).